國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Tumor suppressor Par-4role in cancer...

Rangnekar, Vivek M.

Tumor suppressor Par-4role in cancer and other diseases /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Tumor suppressor Par-4edited by Vivek M. Rangnekar.
其他題名:	role in cancer and other diseases /
其他作者:	Rangnekar, Vivek M.
出版者:	Cham :Springer International Publishing :2021.
面頁冊數:	x, 331 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Tumor suppressor proteins.
電子資源:	https://doi.org/10.1007/978-3-030-80558-6
ISBN:	9783030805586$q(electronic bk.)

Tumor suppressor Par-4role in cancer and other diseases /
Tumor suppressor Par-4role in cancer and other diseases /[electronic resource] :edited by Vivek M. Rangnekar. - Cham :Springer International Publishing :2021. - x, 331 p. :ill., digital ;24 cm.

Par-4 is a naturally occurring tumor suppressor. Studies have indicated that overexpression of Par-4 selectively induces apoptosis in cancer cells while leaving normal, health, cells unaffected. Mechanisms contributing to this cancer-selective action of Par-4 have been associated with PKA activation of intracellular Par-4 in cancer cells or GRP78 expression primarily on the surface of cancer cells. On the other hand, endogenous Par-4 sensitizes cells to the action of a broad range of apoptotic inducers acting via the extrinsic and intrinsic pathways. A number of binding partners of Par-4 have been identified and shown to regulate Par-4 function in cancer and other diseases, such as Alzheimer's and major depression. Recent studies have recognized a number of natural products, dietary supplements, synthetic molecules and FDA-approved drugs that induce the secretion of Par-4 protein to cause apoptosis in primary or metastatic tumors, one of which is in clinical trials. More than 50 different laboratories worldwide are involved in Par-4 based research of this unique protein that has progressed from the bench to clinical trials. This second, companion volume will provide a comprehensive overview of Par-4's role in cancer and other diseases. Chapters are written by leading researchers, and will be useful for a broad audience across the scientific community, particularly students and trainees, who are the next generation of scientists and clinicians to participate in new studies and discoveries on Par-4.

ISBN: 9783030805586$q(electronic bk.)

Standard No.: 10.1007/978-3-030-80558-6doiSubjects--Topical Terms:

489173
Tumor suppressor proteins.

LC Class. No.: QR188.6

Dewey Class. No.: 612.01575

National Library of Medicine Call No.: QZ 202

Tumor suppressor Par-4role in cancer and other diseases /
LDR:02521nmm a2200325 a 4500 001 613753
003 DE-He213
005 20211220115339.0
006 m d
007 cr nn 008maaau
008 220627s2021 sz s 0 eng d
020 $a 9783030805586$q(electronic bk.)
020 $a 9783030805579$q(paper)
024 7 $a 10.1007/978-3-030-80558-6 $2 doi
035 $a 978-3-030-80558-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QR188.6
060 4 $a QZ 202
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 612.01575 $2 23
090 $a QR188.6 $b .T925 2021
245 0 0 $a Tumor suppressor Par-4 $h [electronic resource] : $b role in cancer and other diseases / $c edited by Vivek M. Rangnekar.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a x, 331 p. : $b ill., digital ; $c 24 cm.
520 $a Par-4 is a naturally occurring tumor suppressor. Studies have indicated that overexpression of Par-4 selectively induces apoptosis in cancer cells while leaving normal, health, cells unaffected. Mechanisms contributing to this cancer-selective action of Par-4 have been associated with PKA activation of intracellular Par-4 in cancer cells or GRP78 expression primarily on the surface of cancer cells. On the other hand, endogenous Par-4 sensitizes cells to the action of a broad range of apoptotic inducers acting via the extrinsic and intrinsic pathways. A number of binding partners of Par-4 have been identified and shown to regulate Par-4 function in cancer and other diseases, such as Alzheimer's and major depression. Recent studies have recognized a number of natural products, dietary supplements, synthetic molecules and FDA-approved drugs that induce the secretion of Par-4 protein to cause apoptosis in primary or metastatic tumors, one of which is in clinical trials. More than 50 different laboratories worldwide are involved in Par-4 based research of this unique protein that has progressed from the bench to clinical trials. This second, companion volume will provide a comprehensive overview of Par-4's role in cancer and other diseases. Chapters are written by leading researchers, and will be useful for a broad audience across the scientific community, particularly students and trainees, who are the next generation of scientists and clinicians to participate in new studies and discoveries on Par-4.
650 0 $a Tumor suppressor proteins. $3 489173
650 0 $a Cancer cells. $3 195183
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Oncology. $3 195181
700 1 $a Rangnekar, Vivek M. $3 911774
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-80558-6
950 $a Biomedical and Life Sciences (SpringerNature-11642)